Pennapa Chonpathompikunlert
- Pharmacology top 1%
- Cholinesterase and Neurodegenerative Diseases 5
-
- Medicinal Plants and Neuroprotection 7
- Biochemistry top 10%
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases 5
-
- Alzheimer's disease research and treatments 5
-
- Gut microbiota and health 4
-
- Nanoplatforms for cancer theranostics 4
-
- Neurological Disease Mechanisms and Treatments 4
-
- Liver Disease Diagnosis and Treatment 4
-
- Diet, Metabolism, and Disease 4
- Co-authors
- Jintanaporn WattanathornSupaporn MuchimapuraYukio NagasakiToru YoshitomiAroonsri PripremPilaiwanwadee HutamekalinWanida SukketsiriLong Binh Vong
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Biomaterials (2 papers)
In The Last Decade
Pennapa Chonpathompikunlert
38 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 104
- Pharmacology 347
- Complementary and alternative medicine 264
- Biochemistry 74
- Biological Psychiatry 29
- Pharmacology 186
Countries citing papers authored by Pennapa Chonpathompikunlert
This map shows the geographic impact of Pennapa Chonpathompikunlert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pennapa Chonpathompikunlert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pennapa Chonpathompikunlert more than expected).
Fields of papers citing papers by Pennapa Chonpathompikunlert
This network shows the impact of papers produced by Pennapa Chonpathompikunlert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pennapa Chonpathompikunlert. The network helps show where Pennapa Chonpathompikunlert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pennapa Chonpathompikunlert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 20 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 23 | |
| 11 | 2020 | 62 | |
| 12 | 2018 | 32 | |
| 13 | 2017 | 16 | |
| 14 | 2017 | 34 | |
| 15 | 2015 | 35 | |
| 16 | 2013 | 43 | |
| 17 | 2011 | 35 | |
| 18 | 2010 | 20 | |
| 19 | 2009 | 224 | |
| 20 | 2008 | 157 |
About Pennapa Chonpathompikunlert
Pennapa Chonpathompikunlert is a scholar working on Pharmacology, Complementary and alternative medicine and Biochemistry, having authored 44 papers that have together received 1.1k indexed citations. Recurring topics across this work include Medicinal Plants and Neuroprotection (7 papers), Alzheimer's disease research and treatments (5 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Gut microbiota and health (4 papers), Nanoplatforms for cancer theranostics (4 papers), Neurological Disease Mechanisms and Treatments (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Diet, Metabolism, and Disease (4 papers). The work is most often cited by research in Pharmacology (347 citations), Complementary and alternative medicine (264 citations) and Biochemistry (74 citations). Pennapa Chonpathompikunlert has collaborated with scholars based in Thailand, Japan and Taiwan. Frequent co-authors include Jintanaporn Wattanathorn, Supaporn Muchimapura, Yukio Nagasaki, Toru Yoshitomi, Aroonsri Priprem, Pilaiwanwadee Hutamekalin, Wanida Sukketsiri, Long Binh Vong, Supita Tanasawet and Wanwimol Klaypradit. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.